BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10880372)

  • 61. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.
    Saukkonen K; Nieminen O; van Rees B; Vilkki S; Härkönen M; Juhola M; Mecklin JP; Sipponen P; Ristimäki A
    Clin Cancer Res; 2001 Jul; 7(7):1923-31. PubMed ID: 11448905
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.
    Shappell SB; Manning S; Boeglin WE; Guan YF; Roberts RL; Davis L; Olson SJ; Jack GS; Coffey CS; Wheeler TM; Breyer MD; Brash AR
    Neoplasia; 2001; 3(4):287-303. PubMed ID: 11571629
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder.
    Shirahama T; Sakakura C
    Clin Cancer Res; 2001 Mar; 7(3):558-61. PubMed ID: 11297248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.
    Denkert C; Weichert W; Winzer KJ; Müller BM; Noske A; Niesporek S; Kristiansen G; Guski H; Dietel M; Hauptmann S
    Clin Cancer Res; 2004 Aug; 10(16):5580-6. PubMed ID: 15328200
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The clinical significance of expression of cyclooxygenase-2 gene in breast cancer].
    Guo GL; Yao ZX; Wu J
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1661-4. PubMed ID: 14642098
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
    Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
    Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cyclooxygenase-2 protein expression in relation to apoptotic potential and its prognostic significance in bladder urothelial carcinoma.
    Diamantopoulou K; Lazaris A; Mylona E; Zervas A; Stravodimos K; Nikolaou I; Athanassiadou S; Nakopoulou L
    Anticancer Res; 2005; 25(6C):4543-9. PubMed ID: 16334139
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice.
    Taylor JA; Ristau B; Bonnemaison M; Voznesensky OS; Hegde P; Kuchel GA; Pilbeam CC
    Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):36-41. PubMed ID: 18834948
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder.
    Wadhwa P; Goswami AK; Joshi K; Sharma SK
    Int Urol Nephrol; 2005; 37(1):47-53. PubMed ID: 16132759
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence.
    Friedrich MG; Toma MI; Petri S; Huland H
    BJU Int; 2003 Sep; 92(4):389-92. PubMed ID: 12930427
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas.
    Kubo H; Sumizawa T; Koga K; Nishiyama K; Takebayashi Y; Chuman Y; Furukawa T; Akiyama S; Ohi Y
    Int J Cancer; 1996 Dec; 69(6):488-94. PubMed ID: 8980253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer.
    Badawi AF; Habib SL; Mohammed MA; Abadi AA; Michael MS
    Cancer Invest; 2002; 20(5-6):651-6. PubMed ID: 12197220
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue.
    Sweeney CJ; Marshall MS; Barnard DS; Heilman DK; Billings SD; Cheng L; Marshall SJ; Yip-Schneider MT
    Cancer Detect Prev; 2002; 26(3):238-44. PubMed ID: 12269772
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
    Guo CC; Dadhania V; Zhang L; Majewski T; Bondaruk J; Sykulski M; Wronowska W; Gambin A; Wang Y; Zhang S; Fuentes-Mattei E; Kamat AM; Dinney C; Siefker-Radtke A; Choi W; Baggerly KA; McConkey D; Weinstein JN; Czerniak B
    Eur Urol; 2016 Oct; 70(4):611-620. PubMed ID: 26988609
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer.
    Watkins DN; Lenzo JC; Segal A; Garlepp MJ; Thompson PJ
    Eur Respir J; 1999 Aug; 14(2):412-8. PubMed ID: 10515422
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease.
    Choudhary D; Hegde P; Voznesensky O; Choudhary S; Kopsiaftis S; Claffey KP; Pilbeam CC; Taylor JA
    Urol Oncol; 2015 Sep; 33(9):387.e17-27. PubMed ID: 25618296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.